{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:46:48Z","timestamp":1791384408667,"version":"4.3.3"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background and purpose:<\/jats:title>\n                    <jats:p>Breast cancer is one of the leading causes of death among women worldwide, with rising incidence rates, particularly in rapidly developing countries such as Iran. This study aimed to investigate the relationship between lipid metabolism enzymes, fatty acid synthase (FASN), ATP-citrate lyase (ACLY), and acyl-CoA synthetase long-chain family member 4 (ACSL4), and patient survival, with a focus on their potential role in breast cancer metastasis. In addition, we evaluated the prognostic significance of human epidermal growth factor receptor 2 (HER-2) overexpression in breast cancer patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Experimental approach:<\/jats:title>\n                    <jats:p>A total of 52 breast cancer tissue samples were collected from patients at Ordibehesht Clinic in Isfahan, Iran. RNA was extracted and analyzed using qRT-PCR to quantify the expression of FASN, ACLY, and ACSL4. Kaplan-Meier survival curves and log-rank tests were applied to assess survival rates and metastasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings\/Results:<\/jats:title>\n                    <jats:p>The Kaplan-Meier analysis showed an average time to metastasis of 36.18 months. No significant associations were found between metastasis and the expression levels of ACLY, FASN, or ACSL4. In contrast, HER-2 expression was significantly associated with metastasis, underscoring its potential as a critical prognostic marker. Other clinicopathological factors, including tumor grade, stage, size, and receptor status, were not significantly related to metastasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion and implications:<\/jats:title>\n                    <jats:p>Our study highlights the importance of HER-2 as a key prognostic marker in breast cancer and suggests that further research is required to clarify the mechanisms underlying its role in cancer progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/rps.rps_145_25","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T15:00:24Z","timestamp":1766847624000},"page":"110-121","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Association of fatty acid synthase (FASN), ATP-citrate lyase (ACLY), and acyl-coenzyme A synthetase long-chain 4 (ACSL4) expression and human epidermal growth factor receptor 2 (HER2) status with metastasis and survival in breast cancer: a five-year follow-up"],"prefix":"10.4103","volume":"21","author":[{"given":"Negar","family":"Dinarvand","sequence":"first","affiliation":[{"name":"Hyperlipidemia Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Pourfarzam","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobina","family":"Emadi","sequence":"additional","affiliation":[{"name":"Department of Laboratory Sciences, Khomein University of Medical Sciences, Khomein, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza Karbalaei","family":"Hashemiyan","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Azizi","sequence":"additional","affiliation":[{"name":"Molecular and Medicine Research Center, Khomein University of Medical Sciences, Khomein, Iran"},{"name":"Department of Biochemistry and Genetics, School of Medicine, Arak University of Medical Sciences, Arak, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"issue":"3","key":"R1-20260105","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3892\/br.2016.575","article-title":"Occupational exposure and risk of breast cancer","volume":"4","author":"Fenga","year":"2016","journal-title":"Biomed Rep"},{"issue":"5","key":"R2-20260105","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4103\/RPS.RPS_138_24","article-title":"Clinical relevance of circulating biomarkers in breast cancer metastasis detection:\" insights from liquid biopsy technology\"","volume":"20","author":"Salimi","year":"2025","journal-title":"Res Pharm Sci"},{"issue":"2","key":"R3-20260105","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.19082\/3816","article-title":"Breast cancer research in Iran: a scientometric analysis of publications output from 1991 to 2015 in Scopus","volume":"9","author":"Zarei","year":"2017","journal-title":"Electron Physician"},{"issue":"6","key":"R4-20260105","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/diseases12060111","article-title":"Prognostic factors associated with breast cancer-specific survival from 1995 to 2022: a systematic review and meta-analysis of 1,386,663 cases from 30 countries","volume":"12","author":"Abdul","year":"2024","journal-title":"Diseases"},{"issue":"6","key":"R5-20260105","article-title":"Prognostic factors of recurrence (early and late) and death in breast cancer patients in Iranian women","volume":"9","author":"Akbari","year":"2016","journal-title":"Iran J Cancer Manag"},{"issue":"6","key":"R6-20260105","first-page":"478","article-title":"Is cancer a genetic disease or a metabolic disease?","volume":"2","author":"Wishart","year":"2015","journal-title":"E Bio Medicine"},{"issue":"4","key":"R7-20260105","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.3892\/ol.2016.4988","article-title":"SREBP-1 is an independent prognostic marker and promotes invasion and migration in breast cancer","volume":"12","author":"Bao","year":"2016","journal-title":"Oncol Lett"},{"issue":"2","key":"R8-20260105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2013.05.017","article-title":"Cellular fatty acid metabolism and cancer","volume":"18","author":"Currie","year":"2013","journal-title":"Cell Metab"},{"issue":"1","key":"R9-20260105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4103\/1735-5362.278714","article-title":"Evaluation of long-chain acyl-coenzyme A synthetase 4 (ACSL4) expression in human breast cancer","volume":"15","author":"Dinarvand","year":"2020","journal-title":"Res Pharm Sci"},{"issue":"7-8","key":"R10-20260105","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1002\/jcp.29523","article-title":"Expression and clinicopathological significance of lipin-1 in human breast cancer and its association with p53 tumor suppressor gene","volume":"235","author":"Dinarvand","year":"2020","journal-title":"J Cell Physiol"},{"key":"R11-20260105","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.ejmech.2018.09.001","article-title":"ATP citrate lyase (ACLY) inhibitors: an anti-cancer strategy at the crossroads of glucose and lipid metabolism","volume":"157","author":"Granchi","year":"2018","journal-title":"Eur J Med Chem"},{"issue":"2","key":"R12-20260105","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2174\/1389450115666141224125117","article-title":"ATP citrate lyase (ACLY): a promising target for cancer prevention and treatment","volume":"16","author":"Khwairakpam","year":"2015","journal-title":"Curr Drug Targets"},{"issue":"3","key":"R13-20260105","first-page":"659","article-title":"MiR-22 down-regulates the proto-oncogene ATP citrate lyase to inhibit the growth and metastasis of breast cancer","volume":"10","author":"Liu","year":"2018","journal-title":"Am J Transl Res"},{"issue":"2","key":"R14-20260105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12672-010-0009-7","article-title":"The role of sex steroid receptors on lipogenesis in breast and prostate carcinogenesis: a viewpoint","volume":"1","author":"Rochefort","year":"2010","journal-title":"Horm Cancer"},{"issue":"6","key":"R15-20260105","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.3892\/or.2017.5610","article-title":"Association of long-chain acyl-coenzyme A synthetase 5 expression in human breast cancer by estrogen receptor status and its clinical significance","volume":"37","author":"Yen","year":"2017","journal-title":"Oncol Rep"},{"issue":"17","key":"R16-20260105","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.3390\/cancers13174455","article-title":"Ki-67 as a prognostic biomarker in invasive breast cancer","volume":"13","author":"Davey","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"R17-20260105","first-page":"618698","article-title":"Identification of p53 and its isoforms in human breast carcinoma cells","volume":"2014","author":"Mili\u0107evi\u0107","year":"2014","journal-title":"Scientific World Journal"},{"issue":"6","key":"R18-20260105","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative CT method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"issue":"4","key":"R19-20260105","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1213\/ANE.0000000000005358","article-title":"Kaplan-Meier curves, log-rank tests, and Cox regression for time-to-event data","volume":"132","author":"Schober","year":"2021","journal-title":"Anesth Analg"},{"issue":"5","key":"R20-20260105","doi-asserted-by":"crossref","first-page":"e0155660","DOI":"10.1371\/journal.pone.0155660","article-title":"Systematic analysis of gene expression alterations and clinical outcomes for long-chain acyl-coenzyme A synthetase family in cancer","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS One"},{"key":"R21-20260105","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-981-10-6020-5_10","article-title":"Perspectives of reprogramming breast cancer metabolism","volume":"1026","author":"Wang","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"R22-20260105","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1158\/0008-5472.CAN-15-1646","article-title":"Cyclin E associates with the lipogenic enzyme ATP-citrate lyase to enable malignant growth of breast cancer cells","volume":"76","author":"Lucenay","year":"2016","journal-title":"Cancer Res"},{"issue":"4","key":"R23-20260105","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/iub.1486","article-title":"Tumor-suppressive functions of long-chain acyl-CoA synthetase 4 in gastric cancer","volume":"68","author":"Ye","year":"2016","journal-title":"IUBMB Life"},{"key":"R24-20260105","doi-asserted-by":"crossref","first-page":"104910","DOI":"10.1016\/j.critrevonc.2025.104910","article-title":"Targeting cancer metabolism: therapeutic potential of the fatty acid synthase (FASN) inhibitors","volume":"214","author":"Nuzzo","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"key":"R25-20260105","doi-asserted-by":"crossref","first-page":"1477267","DOI":"10.3389\/fimmu.2024.1477267","article-title":"The pathological significance and potential mechanism of ACLY in cholangiocarcinoma","volume":"15","author":"Sun","year":"2024","journal-title":"Front Immunol"},{"issue":"1","key":"R26-20260105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13000-025-01659-6","article-title":"Long-chain fatty acyl CoA synthetase 4 expression in pancreatic cancer:a marker for malignant lesions and prognostic indicator for recurrence","volume":"20","author":"Uchihara","year":"2025","journal-title":"Diagn Pathol"},{"key":"R27-20260105","doi-asserted-by":"crossref","first-page":"852748","DOI":"10.1155\/2014\/852748","article-title":"Human epidermal growth factor receptor 2 (HER2) in cancers: overexpression and therapeutic implications","volume":"2014","author":"Iqbal","year":"2014","journal-title":"Mol Biol Int"},{"issue":"6","key":"R28-20260105","doi-asserted-by":"crossref","first-page":"626","DOI":"10.4103\/1735-5362.389950","article-title":"Computational design of newly engineered DARPins as HER2 receptor inhibitors for breast cancer treatment","volume":"18","author":"Beheshti","year":"2023","journal-title":"Res Pharm Sci"},{"issue":"2","key":"R29-20260105","first-page":"111","article-title":"Novel agents on the horizon for cancer therapy","volume":"59","author":"Ma","year":"2009","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"R30-20260105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jso.2930490402","article-title":"Clinicopathological significance of c-erbB-2 protein expression in human gastric carcinoma","volume":"49","author":"Tateishi","year":"1992","journal-title":"J Surg Oncol"},{"issue":"6","key":"R31-20260105","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/0046-8177(93)90236-A","article-title":"Double immunostaining for c-erbB-2 and p53 in human stomach cancer cells","volume":"24","author":"Sasano","year":"1993","journal-title":"Hum Pathol"},{"issue":"1","key":"R32-20260105","first-page":"941259","article-title":"HER-2 expression in immunohistochemistry has no prognostic significance in gastric cancer patients","volume":"2012","author":"Halon","year":"2012","journal-title":"ScientificWorldJournal"},{"issue":"3","key":"R33-20260105","first-page":"242","article-title":"Internodal HER2 heterogeneity of axillary lymph node metastases in breast cancer patients","volume":"19","author":"Baro\u0161","year":"2019","journal-title":"Bosn J Basic Med Sci"},{"key":"R34-20260105","doi-asserted-by":"crossref","first-page":"153619","DOI":"10.1016\/j.prp.2021.153619","article-title":"14-3-3\u03b6 promoted invasion and lymph node metastasis of breast invasive ductal carcinoma with HER2 overexpression","volume":"227","author":"Wan","year":"2021","journal-title":"Pathol Res Pract"},{"issue":"1","key":"R35-20260105","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1038\/s41598-020-61567-1","article-title":"HER2 as a potential biomarker of lymph node metastasis in undifferentiated early gastric cancer","volume":"10","author":"Han","year":"2020","journal-title":"Sci Rep"},{"issue":"6","key":"R36-20260105","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.31557\/APJCP.2020.21.6.1559","article-title":"The case-to-case comparison of hormone receptors and HER2 status between primary breast cancer and synchronous axillary lymph node metastasis","volume":"21","author":"Sujarittanakarn","year":"2020","journal-title":"Asian Pac J Cancer Prev"},{"key":"R37-20260105","doi-asserted-by":"crossref","first-page":"153441","DOI":"10.1016\/j.prp.2021.153441","article-title":"Clinicopathologic features of unexpectedly HER2-positive breast carcinomas: an institutional experience","volume":"222","author":"LaBoy","year":"2021","journal-title":"Pathol Res Pract"}],"container-title":["Research in Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/RPS.RPS_145_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:52:23Z","timestamp":1786647143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/RPS.RPS_145_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/rps.rps_145_25","relation":{},"ISSN":["1735-5362","1735-9414"],"issn-type":[{"value":"1735-5362","type":"print"},{"value":"1735-9414","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]},"assertion":[{"value":"2025-08-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}